Impact of autoimmune comorbidity on inflammatory activity and disability accumulation in multiple sclerosis
Multiple Sclerosis and Related Disorders · 2026-05 · 109 · 107149
DOI: 10.1016/j.msard.2026.107149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis and Related Disorders, 2026-05. Verfasst von Shai Shabo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hillel Yaffe Medical Center, Hadera, Israel. Electronic address: ShaiS@hymc.gov.il. Hauptthemen laut MEDLINE: Autoimmune Diseases, Disease Progression, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Autoimmune comorbidities occur more frequently in patients with multiple sclerosis (MS) and have been proposed to exacerbate disease through a putative increase in immune burden. Whether the coexistence of autoimmune disease translates into greater inflammatory activity or accelerated disability progression in relapsing MS remains uncertain. METHODS: We performed a large retrospective matched cohort study using the international MSBase registry, including patients with relapsing - remitting MS or clinically isolated syndrome. Autoimmune comorbidity was defined by documented diagnoses present before or at baseline. Patients with and without autoimmune comorbidity were matched 1:2 using propensity scores. Clinical and radiological outcomes included annualized relapse rate, time to first relapse, MRI inflammatory activity, and 6-month confirmed disability worsening (6M-CDW), analyzed using negative binomial and Cox proportional hazards models. RESULTS: The matched cohort comprised 1773 patients, of whom 591 had at least one autoimmune comorbidity. Autoimmune comorbidity was not associated with higher relapse rates, shorter time to first relapse, or increased MRI inflammatory activity. In contrast, patients with autoimmune comorbidity had a significantly higher risk of confirmed disability worsening over time (hazard ratio 1.21, 95% CI 1.04-1.41). CONCLUSIONS: In relapsing multiple sclerosis, autoimmune comorbidity is not associated with increased relapse activity or inflammatory MRI findings. However, patients with autoimmune comorbidity experience a higher risk of disability worsening over time. This pattern suggests that autoimmune comorbidity does not intensify acute inflammatory disease activity, but may increase susceptibility to chronic, relapse-independent mechanisms of disability accumulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Hillel Yaffe Medical Center, Hadera, Israel. Electronic address: ShaiS@hymc.gov.il.
- Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
- Department of Neurology, Hillel Yaffe Medical Center, Hadera, Israel.
Zitieren
APA
Shabo, S., Yafa Lazar, A., Zmira, O., & MSBase Investigators (2026). Impact of autoimmune comorbidity on inflammatory activity and disability accumulation in multiple sclerosis. Multiple Sclerosis and Related Disorders, 109, 107149. https://doi.org/10.1016/j.msard.2026.107149
Vancouver
Shabo S, Yafa Lazar A, Zmira O, MSBase Investigators. Impact of autoimmune comorbidity on inflammatory activity and disability accumulation in multiple sclerosis. Multiple Sclerosis and Related Disorders. 2026;109:107149. doi:10.1016/j.msard.2026.107149
BibTeX
@article{Shabo2026,
author = {Shabo, Shai and Yafa Lazar, Aviv and Zmira, Ofir and MSBase Investigators, MSBase Investigators},
title = {Impact of autoimmune comorbidity on inflammatory activity and disability accumulation in multiple sclerosis},
journal = {Multiple Sclerosis and Related Disorders},
year = {2026},
volume = {109},
pages = {107149},
doi = {10.1016/j.msard.2026.107149}
}
EUVIMED